Circulating circular RNAs as biomarkers for the diagnosis of essential hypertension with carotid plaque

References

• Cohuet G, Struijker-Boudier H. 2006. Mechanisms of target organ damage caused by hypertension: therapeutic potential. Pharmacol Ther. 111(1):81–98. doi:10.1016/j.pharmthera.2005.09.002.
   PubMed Web of Science ®Google Scholar
• Sillesen H, Sartori S, Sandholt B, Baber U, Mehran R, Fuster V. 2018. Carotid plaque thickness and carotid plaque burden predict future cardiovascular events in asymptomatic adult Americans. Eur Heart J Cardiovasc Imaging. 19(9):1042–50. doi:10.1093/ehjci/jex239.
   PubMed Web of Science ®Google Scholar
• Chen LL. 2020. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 21(8):475–90. doi:10.1038/s41580-020-0243-y.
   PubMed Web of Science ®Google Scholar
• Lu Y, Li Z, Lin C, Zhang J, Shen Z. 2021. Translation role of circRNAs in cancers. J Clin Lab Anal. 35(7):e23866. doi:10.1002/jcla.23866.
   PubMed Web of Science ®Google Scholar
• Li Z, Ruan Y, Zhang H, Shen Y, Li T, Xiao B. 2019. Tumor-suppressive circular RNAs: mechanisms underlying their suppression of tumor occurrence and use as therapeutic targets. Cancer Sci. 110(12):3630–38. doi:10.1111/cas.14211.
   PubMed Web of Science ®Google Scholar
• Zhou WY, Cai ZR, Liu J, Wang DS, Ju HQ, Xu RH. 2020. Circular RNA: metabolism, functions and interactions with proteins. Mol Cancer. 19(1):172. doi:10.1186/s12943-020-01286-3.
   PubMed Web of Science ®Google Scholar
• Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. 2011. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 146(3):353–58. doi:10.1016/j.cell.2011.07.014.
   PubMed Web of Science ®Google Scholar
• Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J, Marzluff WF, Sharpless NE. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013;19(2):141–57. doi:10.1261/rna.035667.112.
   PubMed Web of Science ®Google Scholar
• Wu N, Qadir J, Yang BB. 2022. CircRNA perspective: new strategies for RNA therapy. Trends Mol Med. 28(4):343–44. doi:10.1016/j.molmed.2022.02.002.
   PubMed Web of Science ®Google Scholar
• Chen W, Yu F, Di M, Li M, Chen Y, Zhang Y, Liu X, Huang X, Zhang M. MicroRNA-124-3p inhibits collagen synthesis in atherosclerotic plaques by targeting prolyl 4-hydroxylase subunit alpha-1 (P4HA1) in vascular smooth muscle cells. Atherosclerosis. 2018;277:98–107. doi:10.1016/j.atherosclerosis.2018.08.034.
   PubMed Web of Science ®Google Scholar
• Bao H, Li HP, Shi Q, Huang K, Chen XH, Chen YX, Han Y, Xiao Q, Yao QP, Qi YX. Lamin A/C negatively regulated by miR-124-3p modulates apoptosis of vascular smooth muscle cells during cyclic stretch application in rats. Acta Physiol (Oxf). 2020;228(3):e13374. doi:10.1111/apha.13374.
   PubMed Web of Science ®Google Scholar
• Ye C, Tong Y, Wu N, Wan GW, Zheng F, Chen JY, Lei JZ, Zhou H, Chen AD, Wang JJ, et al. Inhibition of miR-135a-5p attenuates vascular smooth muscle cell proliferation and vascular remodeling in hypertensive rats. Acta Pharmacol Sin. 2021;42(11):1798–807. doi:10.1038/s41401-020-00608-x.
   PubMed Web of Science ®Google Scholar
• Bao X, Zheng S, Mao S, Gu T, Liu S, Sun J, and Zhang L. A potential risk factor of essential hypertension in case-control study: circular RNA hsa_circ_0037911. Biochem Biophys Res Commun. 2018;498(4):789–94. doi:10.1016/j.bbrc.2018.03.059.
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the american college of cardiology/American heart association task force on clinical practice guidelines. Hypertension. 2018;71(6):e13–e115. doi:10.1161/HYP.0000000000000065.
   PubMed Web of Science ®Google Scholar
• Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Fatar M, et al. Mannheim carotid intima-media thickness consensus (2004-2006). an update on behalf of the advisory board of the 3rd and 4th watching the risk symposium, 13th and 15th European stroke conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis. 2007;23(1):75–80. doi:10.1159/000097034.
   PubMed Web of Science ®Google Scholar
• John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. 2004. Human MicroRNA targets. PLoS Biol. 2(11):e363. doi:10.1371/journal.pbio.0020363.
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–504. doi:10.1101/gr.1239303.
   PubMed Web of Science ®Google Scholar
• Tokar T, Pastrello C, Rossos AEM, Abovsky M, Hauschild AC, Tsay M, Lu R, Jurisica I. mirDIP 4.1-integrative database of human microRNA target predictions. Nucleic Acids Res. 2018;46(D1):D360–D70. doi:10.1093/nar/gkx1144.
   PubMed Web of Science ®Google Scholar
• Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, Imamichi T, Chang W. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. [cited 2022 Mar 23]. Epub ahead of print. doi:10.1093/nar/gkac194.
   PubMed Web of Science ®Google Scholar
• Perrone-Filardi P, Coca A, Galderisi M, Paolillo S, Alpendurada F, de Simone G, Donal E, Kahan T, Mancia G, Redon J, et al. Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus paper from the European association of cardiovascular imaging (EACVI), the European society of Cardiology council on hypertension, and the European society of hypertension (ESH). Eur Heart J Cardiovasc Imaging. 2017;18(9):945–60. doi:10.1093/ehjci/jex094.
   PubMed Web of Science ®Google Scholar
• Piskorz D. 2020. Hypertensive mediated organ damage and hypertension management. how to assess Beneficial effects of antihypertensive treatments? High Blood Press Cardiovasc Prev. 27(1):9–17. doi:10.1007/s40292-020-00361-6.
   PubMed Web of Science ®Google Scholar
• Song P, Fang Z, Wang H, Cai Y, Rahimi K, Zhu Y, Fowkes FGR, Fowkes FJI, Rudan I. Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study. Lancet Glob Health. 2020;8(5):e721–e9. doi:10.1016/S2214-109X(20)30117-0.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhou M, Yant L, Huang C. Circular RNA in disease: basic properties and biomedical relevance. Wiley Interdiscip Rev RNA. 2022;e1723. doi:10.1002/wrna.1723.
   PubMed Web of Science ®Google Scholar
• Fasolo F, Di Gregoli K, Maegdefessel L, Johnson JL. 2019. Non-coding RNAs in cardiovascular cell biology and atherosclerosis. Cardiovasc Res. 115(12):1732–56. doi:10.1093/cvr/cvz203
   PubMed Web of Science ®Google Scholar
• Peng W, Li S, Chen S, Yang J, Sun Z. Hsa_circ_0003204 knockdown weakens Ox-LDL-Induced cell injury by regulating miR-188-3p/TRPC6 axis in human carotid artery endothelial cells and THP-1 cells. Front Cardiovasc Med. 2021;8:731890. doi:10.3389/fcvm.2021.731890.
   PubMed Web of Science ®Google Scholar
• Luo L, Wang Y, Hu P, Wu J. Long non-coding RNA metastasis associated lung adenocarcinoma transcript 1 (MALAT1) promotes hypertension by modulating the Hsa-miR-124-3p/nuclear receptor subfamily 3, group C, member 2 (NR3C2) and Hsa-miR-135a-5p/NR3C2 axis. Med Sci Monit. 2020;26:e920478. doi:10.12659/MSM.920478.
   PubMed Web of Science ®Google Scholar
• Wen G, Zhou T, Gu W. 2021. The potential of using blood circular RNA as liquid biopsy biomarker for human diseases. Protein Cell. 12(12):911–46. doi:10.1007/s13238-020-00799-3.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li Y, Zang J, Zhang T, Li Y, Tan Z, Ma D, Zhang T, Wang S, Zhang Y, et al. CircOGDH is a penumbra biomarker and therapeutic target in acute ischemic stroke. Circ Res. 2022;130(6):907–24. doi:10.1161/CIRCRESAHA.121.319412.
   PubMed Web of Science ®Google Scholar
• Zuo L, Zhang L, Zu J, Wang Z, Han B, Chen B, Cheng M, Ju M, Li M, Shu G, et al. Circulating circular RNAs as biomarkers for the diagnosis and prediction of outcomes in acute ischemic stroke. Stroke. 2020;51(1):319–23. doi:10.1161/STROKEAHA.119.027348.
   PubMed Web of Science ®Google Scholar
• Wang L, Shen C, Wang Y, Zou T, Zhu H, Lu X, Li L, Yang B, Chen J, Chen S, et al. Identification of circular RNA Hsa_circ_0001879 and Hsa_circ_0004104 as novel biomarkers for coronary artery disease. Atherosclerosis. 2019;286:88–96. doi:10.3389/fcell.2021.652032.
   PubMed Web of Science ®Google Scholar
• Yuan P, Wu WH, Gong SG, Jiang R, Zhao QH, Pudasaini B, Sun YY, Li JL, Liu JM, Wang L, et al. Impact of circGSAP in peripheral blood mononuclear cells on idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med. 2021;203(12):1579–83. doi:10.1164/rccm.202005-2052LE.
   PubMed Web of Science ®Google Scholar
• Bauer M, Caviezel S, Teynor A, Erbel R, Mahabadi AA, Schmidt-Trucksass A. Carotid intima-media thickness as a biomarker of subclinical atherosclerosis. Swiss Med Wkly. 2012;142:w13705. doi:10.4414/smw.2012.13705.
   PubMed Web of Science ®Google Scholar
• Takiuchi S, Kamide K, Miwa Y, Tomiyama M, Yoshii M, Matayoshi T, Horio T, Kawano Y. Diagnostic value of carotid intima-media thickness and plaque score for predicting target organ damage in patients with essential hypertension. J Hum Hypertens. 2004;18(1):17–23. doi:10.1038/sj.jhh.1001628.
   PubMed Web of Science ®Google Scholar
• Willeit P, Tschiderer L, Allara E, Reuber K, Seekircher L, Gao L, Liao X, Lonn E, Gerstein HC, Yusuf S, et al. Carotid intima-media thickness progression as surrogate marker for cardiovascular risk: meta-analysis of 119 clinical trials involving 100 667 patients. Circulation. 2020;142(7):621–42. doi:10.1161/CIRCULATIONAHA.120.046361.
   PubMed Web of Science ®Google Scholar
• Tay Y, Rinn J, and Pandolfi PP. 2014. The multilayered complexity of ceRNA crosstalk and competition. Nature. 505(7483):344–52. doi:10.1038/nature12986.
   PubMed Web of Science ®Google Scholar
• Fuster JJ, MacLauchlan S, Zuriaga MA, Polackal MN, Ostriker AC, Chakraborty R, Wu CL, Sano S, Muralidharan S, Rius C, et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science. 2017;355(6327):842–47. doi:10.1126/science.aag1381.
   PubMed Web of Science ®Google Scholar
• de Bruin RG, Shiue L, Prins J, de Boer HC, Singh A, Fagg WS, van Gils JM, Duijs JM, Katzman S, Kraaijeveld AO, et al. Quaking promotes monocyte differentiation into pro-atherogenic macrophages by controlling pre-mRNA splicing and gene expression. Nat Commun. 2016;7:10846 doi:10.1038/ncomms10846.
   PubMed Web of Science ®Google Scholar
• Du H, Yang L, Zhang H, Zhang X, Shao H. LncRNA TUG1 silencing enhances proliferation and migration of ox-LDL-treated human umbilical vein endothelial cells and promotes atherosclerotic vascular injury repairing via the Runx2/ANPEP axis. Int J Cardiol. 2021;338:204–14. doi:10.1016/j.ijcard.2021.05.014.
   PubMed Web of Science ®Google Scholar
• Centa M, Jin H, Hofste L, Hellberg S, Busch A, Baumgartner R, Verzaal, NJ, Lind Enoksson S, Perisic Matic L, Boddul SV, et al. Germinal center-derived antibodies promote atherosclerosis plaque size and stability. Circulation. 2019;139(21):2466–82. doi:10.1161/CIRCULATIONAHA.118.038534.
   PubMed Web of Science ®Google Scholar
• Guo J, Mei H, Sheng Z, Meng Q, Veniant MM, and Yin H. 2020. Hsa-miRNA-23a-3p promotes atherogenesis in a novel mouse model of atherosclerosis. J Lipid Res. 61(12):1764–75. doi:10.1194/jlr.RA120001121.
   PubMed Web of Science ®Google Scholar
• Prestel M, Prell-Schicker C, Webb T, Malik R, Lindner B, Ziesch N, Rex-Haffner M, Röh S, Viturawong T, Lehm M, et al. The atherosclerosis risk variant rs2107595 mediates allele-specific transcriptional regulation of HDAC9 via E2F3 and Rb1. Stroke. 2019;50(10):2651–60. doi:10.1161/STROKEAHA.119.026112.
   PubMed Web of Science ®Google Scholar
• Bobryshev YV, Shchelkunova TA, Morozov IA, Rubtsov PM, Sobenin IA, Orekhov AN, Smirnov AN. Changes of lysosomes in the earliest stages of the development of atherosclerosis. J Cell Mol Med. 2013;17(5):626–35. doi:10.1111/jcmm.12042.
   PubMed Web of Science ®Google Scholar
• Huang T, Zhao HY, Zhang XB, Gao XL, Peng WP, Zhou Y, Zhao WH, Yang HF. LncRNA ANRIL regulates cell proliferation and migration via sponging miR-339-5p and regulating FRS2 expression in atherosclerosis. Eur Rev Med Pharmacol Sci. 2020;24(4):1956–69. doi:10.26355/eurrev_202002_20373.
   PubMed Web of Science ®Google Scholar
• Pirillo A, Svecla M, Catapano AL, Holleboom AG, and Norata GD. 2021. Impact of protein glycosylation on lipoprotein metabolism and atherosclerosis. Cardiovasc Res. 117(4):1033–45. doi:10.1093/cvr/cvaa252.
   PubMed Web of Science ®Google Scholar
• Ye Z, Guo H, Wang L, Li Y, Xu M, Zhao X, Song, X, Chen Z, Huang R. GALNT4 primes monocytes adhesion and transmigration by regulating O-Glycosylation of PSGL-1 in atherosclerosis. J Mol Cell Cardiol. 2022;165:54–63. doi:10.1016/j.yjmcc.2021.12.012.
   PubMed Web of Science ®Google Scholar
• Plummer AM, Culbertson AT, Liao M. The ABCs of Sterol Transport. Annu Rev Physiol. 2021;83:153–81. doi:10.1146/annurev-physiol-031620-094944.
   PubMed Web of Science ®Google Scholar
• Xu F, Shen L, Chen H, Wang R, Zang T, Qian J, Ge J. circDENND1B participates in the antiatherosclerotic effect of IL-1beta monoclonal antibody in mouse by promoting cholesterol efflux via miR-17-5p/Abca1 Axis. Front Cell Dev Biol. 2021;9:652032. doi:10.3389/fcell.2021.652032.
   PubMed Web of Science ®Google Scholar
• Yu Z, Peng Q, Huang Y. 2019. Potential therapeutic targets for atherosclerosis in sphingolipid metabolism. Clin Sci (Lond). 133(6):763–76. doi:10.1042/CS20180911
   PubMed Web of Science ®Google Scholar
• Hannun YA, Obeid LM. 2018. Sphingolipids and their metabolism in physiology and disease. Nat Rev Mol Cell Biol. 19(3):175–91. doi:10.1038/nrm.2017.107.
   PubMed Web of Science ®Google Scholar